Skip to main content
. 2011 Aug 18;11:45. doi: 10.1186/1471-2318-11-45

Table 4.

Prevalence of comorbidity by gender.

Men
n = 13,370
Women
n = 31,572
Total
N = 44,942
Median (IQ) age adjusted CCI 5 (4-6) 5 (4-6) 5 (4-6)
Any comorbid condition 30.7 (30.0-31.5) 23.7 (23.2-24.2) 25.8 (25.4-26.2)
Diabetes 10.0 (9.5-10.6) 7.0 (6.7-7.3) 7.9 (7.6-8.1)
Renal disease 6.8 (6.3-7.2) 3.9 (3.7-4.1) 4.8 (4.6-5.0)
Dementia 3.7 (3.4-4.1) 3.4 (3.2-3.6) 3.5 (3.3-3.7)
Congestive heart failure 3.4 (3.1-3.7) 2.7 (2.5-2.9) 2.9 (2.7-3.1)
Pulmonary disease 3.4 (3.1-3.7) 2.0 (1.8-2.1) 2.4 (2.2-2.5)
Parkinson's disease 3.1 (2.8-3.4) 1.4 (1.3-1.6) 1.9 (1.8-2.0)
Cerebral vascular accident 2.7 (2.4-3.0) 1.4 (1.2-1.5) 1.8 (1.6-1.9)
Cancer 2.6 (2.3-2.9) 1.0 (0.9-1.2) 1.5 (1.4-1.6)
Paraplegia 1.9 (1.7-2.1) 0.9 (0.8-1.0) 1.2 (1.1-1.3)
Delirium 1.5 (1.3-1.7) 1.2 (1.1-1.4) 1.3 (1.2-1.4)
Osteoporosis 1.2 (1.0-1.4) 3.3 (3.1-3.5) 2.7 (2.5-2.8)
Metastatic cancer 1.2 (1.0-1.4) 0.5 (0.4-0.6) 0.7 (0.6-0.8)
Acute myocardial infarction 1.1 (0.9-1.3) 0.9 (0.8-1.0) 0.9 (0.9-1.0)
Vision impairment 1.0 (0.8-1.2) 1.0 (0.9-1.1) 1.0 (0.9-1.1)
Deafness 0.8 (0.7-1.0) 0.6 (0.5-0.7) 0.7 (0.6-0.8)
Peripheral vascular disease 0.6 (0.5-0.8) 0.3 (0.3-0.4) 0.4 (0.4-0.5)
Liver disease 0.2 (0.1-0.3) 0.1 (0.0-0.1) 0.1 (0.1-0.1)
Ataxia 0.2 (0.1-0.3) 0.1 (0.1-0.2) 0.1 (0.1-0.2)
Connective tissue disorder 0.1 (0.1-0.2) 0.4 (0.3-0.4) 0.3 (0.3-0.4)
Severe liver disease 0.1 (0.1-0.2) 0.0 (0.0-0.1) 0.1 (0.0-0.1)
Peptic ulcer 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.1 (0.1-0.2)

Values are percentages (95% confidence intervals) unless stated otherwise*

IQ - interquartile range. CCI-Charlson comorbidity index.

* Neuromyalgia and HIV not shown because of very low prevalence (0.01% for each condition).

† Non-parametric K sample test for equality of medians.

‡ Diabetes with or without complications. The prevalence of diabetes with complications was 4.8% (4.5-5.2) in men, 3.3% (3.1-3.5) in women, and 3.7% (3.6-3.9) overall. The prevalence of diabetes without complications was 6.1% (5.7-6.5) in men, 4.0% (3.8-4.3) in women, and 4.7% (4.5-4.9) overall.